Ungar R, Wu L, MacLeod S, Tkatch R, Huang J, Kraemer S, Schaffer J, Yeh C. The impact of COVID-19 on older adults: results from an annual survey. Geriatr Nurs. 2022 Mar;44:131-6. doi: 10.1016/j.gerinurse.2022.01.010
MacLeod S, Musich S, Kraemer S, Wicker E. Practical non-pharmacological intervention approaches for sleep problems among older adults. Geriatr Nurs. 2018 Sep;39(5):506-12. doi: 10.1016/j.gerinurse.2018.02.002
Tkatch R, Musich S, MacLeod S, Kraemer S, Hawkins K, Wicker ER, Armstrong DG. A qualitative study to examine older adults' perceptions of health: Keys to aging successfully. Geriatr Nurs. 2017 Nov;38(6):485-90. doi: 10.1016/j.gerinurse.2017.02.009
Davis AE, Brogan AJ, Goodwin B, Nocea G, Lozano V. Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain. HIV Clin Trials. 2017 Nov;18(5-6):214-22. doi: 10.1080/15284336.2017.1402144
MacLeod S, Musich S, Gulyas S, Cheng Y, Tkatch R, Cempellin D, Bhattarai GR, Hawkins K, Yeh CS. The impact of inadequate health literacy on patient satisfaction, healthcare utilization, and expenditures among older adults. Geriatr Nurs. 2017 Jul;38(4):334-41. doi: 10.1016/j.gerinurse.2016.12.003
MacLeod S, Musich S, Hawkins K, Alsgaard K, Wicker ER. The impact of resilience among older adults. Geriatr Nurs. 2016 Jul;37(4):266-72. doi: 10.1016/j.gerinurse.2016.02.014
Brogan AJ, Mrus J, Hill A, Sawyer AW, Smets E. Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States. HIV Clin Trials. 2010 May;11(3):133-44.